Follow
David Brown
David Brown
KBI Biopharma
Verified email at kbibiopharma.com
Title
Cited by
Cited by
Year
Nox proteins in signal transduction
DI Brown, KK Griendling
Free Radical Biology and Medicine 47 (9), 1239-1253, 2009
10402009
Regulation of signal transduction by reactive oxygen species in the cardiovascular system
DI Brown, KK Griendling
Circulation research 116 (3), 531-549, 2015
5492015
Doxorubicin exposure causes subacute cardiac atrophy dependent on the striated muscle–specific ubiquitin ligase MuRF1
MS Willis, TL Parry, DI Brown, RI Mota, W Huang, JY Beak, M Sola, ...
Circulation: Heart Failure 12 (3), e005234, 2019
1222019
NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor
A Martin-Garrido, DI Brown, AN Lyle, A Dikalova, B Seidel-Rogol, ...
Free Radical Biology and Medicine 50 (2), 354-362, 2011
982011
Poldip2 knockout results in perinatal lethality, reduced cellular growth and increased autophagy of mouse embryonic fibroblasts
DI Brown, B Lassègue, M Lee, R Zafari, JS Long, HI Saavedra, ...
PLoS One 9 (5), e96657, 2014
452014
Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4
Q Xu, AA Kulkarni, AM Sajith, D Hussein, D Brown, OF Güner, MD Reddy, ...
Bioorganic & medicinal chemistry 26 (5), 989-998, 2018
342018
Cessation of biomechanical stretch model of C2C12 cells models myocyte atrophy and anaplerotic changes in metabolism using non-targeted metabolomics analysis
A Ilaiwy, MT Quintana, JR Bain, MJ Muehlbauer, DI Brown, WE Stansfield, ...
The international journal of biochemistry & cell biology 79, 80-92, 2016
222016
Influence of Ischemia-Reperfusion Injury on Cardiac Metabolism
DI Brown, MS Willis, JM Berthiaume
The Scientist's Guide to Cardiac Metabolism, 155-167, 2016
152016
Ubiquitin ligases and posttranslational regulation of energy in the heart: the hand that feeds
DI Brown, TL Parry, MS Willis
Comprehensive Physiology 7 (3), 841-862, 2011
122011
Nebulized delivery of the MAPKAP kinase 2 peptide inhibitor MMI-0100 protects against ischemia-induced systolic dysfunction
DI Brown, BC Cooley, MT Quintana, C Lander, MS Willis
International journal of peptide research and therapeutics 22, 317-324, 2016
102016
Erratum to'Cessation of biomechanical stretch model of C2C12 cells modelsmyocyte atrophy and anaplerotic changes in metabolism usingnon-targeted metabolomics analysisAmro'[Int …
A Ilaiwy, MT Quintana, JR Bain, MJ Muehlbauer, DI Brown, WE Stansfield, ...
The international journal of biochemistry & cell biology 88, 238-240, 2017
12017
NADPH oxidase inhibitors and uses thereof
O Güner, B Lassegue, K Griendling, Q Xu, D Brown, JP Bowen, A Kulkarni, ...
US Patent 11,236,053, 2022
2022
Muscle Ring Finger‐1 Knockout (MuRF1−/−) Mice are Resistant to LPS‐induced Cardiac Dysfunction Due to Decreased NF‐κB Activity
TL Parry, DI Brown, JM Mwiza, MS Willis
The FASEB Journal 31, 59.6-59.6, 2017
2017
The absence of MuRF1 protects against Calpain1‐induced systolic dysfunction in vivo
D Brown, J Robbins*, M Willis
The FASEB Journal 29, 46.1, 2015
2015
Poldip2: an investigation of structure and signaling pathways to elucidate the function of a novel cell cycle regulator.
DI Brown
Emory University, 2013
2013
TGFβ Induction of Vascular Smooth Muscle Differentiation Markers is Mediated by Nox4 and p38 Mitogen-activated Protein Kinase
A Martin-Garrido, DI Brown, AN Lyle, A Dikalova, KK Griendling
Circulation 120 (suppl_18), S1098-S1098, 2009
2009
FRET Study of CAD-Rad9 Protein-Protein Interaction
DI Brown, EM Wauson, LM Graves
The FASEB Journal 20 (4), A46-A46, 2006
2006
The system can't perform the operation now. Try again later.
Articles 1–17